GM1
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Phase 1/2 Study of Intravenous Gene Transfer With an AAV9 Vector Expressing Human Beta-galactosidase in Type I and Type II GM1 Gangliosidosis (NCT03952637) | National Human Genome Research Institute (NHGRI) | 2019-08-19 |
Track GM1 automatically
Every clearance here is in the API, with alerts when new ones post.